| Overview |
| bs-23419r-apc-cy55-100l |
| ABCA1 Polyclonal Antibody, APC-Cy5.5 Conjugated |
| IF |
| Human |
| Mouse, Rat |
| Specifications |
| APC-Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human ABCA1 |
| 501-600/2261 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Affinity purified by Protein A |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 19 |
| O95477 |
| Extracellular |
| ABC-1; ABC1; CERP; HDLCQTL13; TGD; ABCA1_HUMAN; ABCA1; ATP-binding cassette sub-family A member 1; ATP-binding cassette transporter 1 (ABC-1 | ATP-binding cassette 1); cassette subfamily A member 1; ATP-binding cassette, sub-family A (ABC1), member 1; Tangier disease |
| ABCA1 is a membrane-associated ATP-binding cassette transporter involved in cellular lipid homeostasis. It promotes the efflux of cholesterol and phospholipids to apolipoproteins, supporting the formation of nascent high-density lipoproteins (HDLs). ABCA1 preferentially transports phosphatidylcholine and plays an important role in cholesterol removal pathways. Mutations in ABCA1 are associated with Tangier disease and familial HDL deficiency, making it a relevant marker for lipid metabolism, cholesterol transport, cardiovascular research, and related disease studies. |
| Application Dilution |
| IF |
1:100-500 |
Powered by Bioz